Tag archives

treatment-access

Publisher: Open Society Foundations

The affordability, availability, and financing of medicines and other health commodities has always been a central issue for the Global Fund to Fight AIDS, Tuberculosis, and Malaria, its donors, recipient countries, and affected communities. Given the significant amount and proportion of Global Fund grant funding that goes to health commodities procurement, the strategic and operational components of their procurement and price strategies, and the availability of suppliers and access to their products, are key to ensuring availability and affordability of medicines.

Current and proposed policies have created a growing concern that the Global Fund is fundamentally altering its approach to access to medicines. There appears to be a progressive rollback of its previous position of...


This entry was posted in and tagged on by .

Publisher: Open Society Foundations

This report reflects on the founding values of the Global Fund, where it has made progress and where it has fallen short. It outlines three critical areas that require attention and advocacy:

realizing the Global Fund’s human rights objectives preserving support in middle income countries supporting access to medicines for all at the lowest possible price

A period of changing global health governance and a dramatically shifting geography of poverty are part of the context for this briefing paper’s consideration of the impact of changes at the Global Fund to Fight AIDS, TB, and Malaria, including the Fund’s so-called New Funding Model.

This report is a resource for advocates working to assess the impact of the New Funding Model and to help shape the next five-year strategy.


This entry was posted in and tagged , , , on by .

Publisher:  All-Party Parliamentary Group on HIV and AIDS

This report is the product of an almost year-long inquiry into the availability and affordability of drugs and diagnostics across the developing world. According to the All-Party Parliamentary Group on HIV and AIDS, despite notable success in the global AIDS response, access to medicines is threatened by withdrawal of funding in middle-income countries, the imposition of ever stricter rules on intellectual property, a failure to reach key population groups like LGBT people, sex workers and people who inject drugs, and insufficient R&D for child-friendly anti-retrovirals and treatments for HIV co-infections like TB.

Access Denied report calls for:

Review of funding decisions affecting middle income countries Global Fund leadership on Hepatitis C treatment Action to support use of TRIPS flexibilities to overcome high medicine prices Review of patent-ba...
This entry was posted in and tagged on by .

Publisher: Health GAP

An international civil society letter endorsed by 220 organisations, recommending that Dr Mark Dybul stop pursuing an initiative on tiered pricing to address the lack of access to affordable medicines in middle income countries.

Mark Dybul’s response
Equitable Access Initiative proposal
Critical analysis of the Equitable Access Initiative


This entry was posted in and tagged on by .